Skip to main content

Table 2 Study Characteristics

From: Deflazacort for the treatment of Duchenne Dystrophy: A systematic review

Study No.

Author (s)

Year

Source

Publication Status

Inclusion Criteria Met

Reason for Exclusion

A

Bonifati et al. [19]

2000

Muscle and Nerve

Article

Yes

-

B

Angelini et al. [20]

1994

Muscle and Nerve

Article

Yes

-

C

Mesa et al. [21]

1991

Neuromuscular Disorders

Article

No

Not randomized.

D

Reitter [22]

1995

Brain and Development

Article

No

Interim report of a trial. No results by treatment given.

E

Luz et al. [23]

1982

Revista Chilena de Pediatria

Article

No

Not randomized.

F

Angelini et al. [24]

1998

Muscle and Nerve

Abstract

Yes

-

G

Angelini et al. [25]

1995

Neurology

Abstract

Yes

-

H

Reitter [26]

1995

Developmental Medicine and Child Neurology

Abstract

No

Interim report of a trial. No results by treatment given.

I

Winter et al. [27]

1999

Acta Myologica

Article

No

No strength or side effect data reported.

J

Rietter [28]

1995

Monatsschrift fur Kinderheilkunde

N/A

N/A

Not retrieved. Felt to be a duplicate publication.

K

Todorovic et al. [29]

1998

Muscle and Nerve

Abstract

No

DFZ not used.

L

Reitter [13]

1998

Neuromuscular Disorders

Meeting Proceeding

No

Report of randomized trial but no specific outcomes reported.

M

Dubrovsky et al. [30]

1999

Neurology

Abstract

No

Not randomized

N

Brooke [12]

1996

Neurology

Abstract

Yes

-

O

ENMC Workshop [31]

1997

Neuromuscular Disorders

Meeting Proceeding

No

Report of randomized trial but no specific outcomes reported.

  1. ENMC = European Neuromuscular Centre